Senior Research Fellow, Prostate Group Lead
A/Prof David Smith is an epidemiologist and heads the Prostate Cancer Group. He has published and presented extensively in cancer epidemiology and outcomes research. His major interest is in prostate cancer, specifically in the epidemiology of the disease, the effect of PSA testing on the population trends and in the patterns and outcomes of care for prostate cancer.
- PhD (Public Health), The University of Sydney
- Master of Public Health, The University of Sydney
- Bachelor of Arts (English/History), University of Canterbury (NZ)
- Centre for Research Excellence in Prostate Cancer Survivorship (CRE-PCS), Centre of Research Excellence Grant, National Health and Medical Research Council (NHMRC)
- A phase II randomised controlled trial of high dose Vitamin D in localised prostate cancer cases with intermediate risk of progression (Pros-D), Project Grant, Prostate Cancer Foundation of Australia (PCFA)
- Improving evidence-based care for locally advanced prostate cancer – a randomised phased trial of clinical guideline implementation through a clinical network, Project Grant, NHMRC Partnership Grant, PCFA
- Testing and treatment for prostate cancer in Australia: epidemiology and modelling, Project Grant, PCFA
- Developing a Patient-Reported Symptom Index for Non-muscle Invasive Bladder Cancer, Project Grant, Cancer Council Australia/Cancer Council NSW
- Fifteen year quality of life, survivorship and survival outcomes for prostate cancer: The NSW Prostate Cancer Care and Outcomes Study, Career Development Fellowship Grant, Cancer Institute NSW
- Stratifying prostate cancer risk in the 45 and Up Study: enhancing clinical information for risk groups at diagnosis, Project Grant, Cancer Council Australia
Adjunct Associate Professor, The University of Sydney
Adjunct Associate Professor, Monash University
Adjunct Associate Professor, Griffith University
Current student supervision
Ben Gallagher, The University of Sydney, Thesis, Socioeconomic status and prostate cancer treatment and survival
Ankur Arya, The University of Sydney, Thesis, Geographical and Temporal Distribution of Prostate Specific Antigen Testing Across Australia
David is available to supervise PhD students enrolled at The University of Sydney.
Selected key publications
Mazariego CG, Juraskova I, Campbell R, Smith DP. Long-term unmet supportive care needs of prostate cancer survivors: 15-year follow-up from the NSW Prostate Cancer Care and Outcomes Study. Support Care Cancer. 2020 Mar 16. doi: 10.1007/s00520-020-05389-x.
Egger S, Smith DP, Brown BB, Kneebone AB, Dominello A, Brooks AJ, Young J, Xhilaga M, Haines M, O’Connell DL. Urologists’ referral and radiation oncologists’ treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis. J Med Imaging Radiat Oncol. 2020 Feb;64(1):134-143. doi: 10.1111/1754-9485.12979. Epub 2019 Dec 2
Smith DP, Calopedos R, Bang A, Yu XQ, Egger S, Chambers S, O’Connell DL. Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data. PLoS One. 2018 Jun 13;13(6):e0198679. doi: 10.1371/journal.pone.0198679. eCollection 2018.
Nair-Shalliker V, Bang A, Weber M, Goldsbury DE, Caruana M, Emery J, Banks E, Canfell K, O’Connell DL, Smith DP. Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study. Sci Rep. 2018 Mar 9;8(1):4261. doi: 10.1038/s41598-018-22589-y
Egger SJ, Calopedos RJ, O’Connell DL, Chambers SK, Woo HH, Smith DP. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer. Eur Urol. 2017 Aug 26. pii: S0302-2838(17)30699-1. doi: 10.1016/j.eururo.2017.08.013.